RecruitingNot Applicable

Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment

Spain60 participantsStarted 2024-10-04

Plain-language summary

The purpose of this study is to find out if adding virtual reality (VR) to a cognitive training program helps improve cognitive performance in older adults with mild cognitive impairment (MCI). In this study, all participants will take part in a 12-week computer-based cognitive rehabilitation program. One group will also use immersive VR for 15-20 minutes at the end of each session. Participants will attend 2 sessions per week, completing at least 20 sessions and up to 22, depending on the clinic's schedule. Researchers will measure changes in attention, memory, and thinking skills using standard cognitive tests. They will also collect feedback on how participants experience the VR exercises.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 60 or older * Clinical diagnosis of mild cognitive impairment (MCI) * Preserved autonomy in basic and instrumental activities of daily living * MoCA score between 18 and 26 * Ability to use a computer interface with or without assistance * Capacity to understand and sign informed consent Exclusion Criteria: * Diagnosis of dementia (MMSE \< 18 or clinical judgment) * Severe visual or hearing impairment affecting task participation * History of epilepsy, vertigo, or conditions contraindicating VR use * Severe psychiatric or neurological illness (e.g., major depression, Parkinson's disease) * Enrollment in other cognitive training programs during the study period

What they're measuring

Global Cognition as Measured by the Montreal Cognitive Assessment (MoCA)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Global Cognition as Measured by the Mini-Mental State Examination (MMSE)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Short-Term Memory as Measured by the Digit Span Test (Forward Span)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Working Memory as Measured by the Digit Span Test (Backward Span)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Visuospatial Attention as Measured by the Trail Making Test Part A (TMT-A)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Executive Function as Measured by the Trail Making Test Part B (TMT-B)

Timeframe: Baseline and immediately post-intervention (Week 12, within 1 week after last session)

Processing Speed as Measured by the Symbol Digit Modalities Test (SDMT)

Trial details

NCT IDNCT06977815

SponsorBadalona Serveis Assistencials

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12

Contact for this trial

José Ferrer Costa, MD

0034935074710 jfcosta@bsa.cat

View on ClinicalTrials.gov More Mild Cognitive Impairment trials